Andrew Kirby

6PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersElectrical circuits and systemsCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 12, 2026
Tranexamic acid to prevent anastomotic leak after rectal cancer surgery: protocol for a feasibility trial with embedded mechanistic analysis of the microbiome.

|May 24, 2024
Multidrug-Resistant Escherichia coli Remains Susceptible to Metal Ions and Graphene-Based Compounds.

Nathalie Karaky, Shiying Tang, Parameshwari Ramalingam

|Mar 07, 2020
The CABI Trial: an Unblinded Parallel Group Randomised Controlled Feasibility Trial of Long-Course Antibiotic Therapy (28 Days) Compared with Short Course (≤ 10 Days) in the Prevention of Relapse in Adults Treated for Complicated Intra-Abdominal Infection.

Shadia Ahmed, Rory Brown, Richard Pettinger

|Sep 09, 2019
A pharmacokinetic-pharmacodynamic assessment of oral antibiotics for pyelonephritis.

J W S Cattrall, E Asín-Prieto, J Freeman

|Dec 07, 2018
Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion-dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery.

Andrew Kirby, Eduardo Asín-Prieto, Flora Agnes Burns

|Sep 08, 2018
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.

Jonathan W S Cattrall, Alyss V Robinson, Andrew Kirby

Pageof 1

Frequent Collaborators

1 joint publications

Shadia Ahmed

1 joint publications

Rory Brown

1 joint publications

Richard Pettinger

1 joint publications

Armando Vargas-Palacios